FDAFDA · Food and drugs·Recall number D-0840-2020
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Published February 19, 2020 · Recall initiated: January 28, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- B AND A TRADING CORPORATION
- Distributor
- NY & NJ only
- Lot
- Lot #: H003
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.